World Trade Center Health Program Scientific/Technical Advisory Committee, 34159-34161 [2023-11327]
Download as PDF
<![CDATA[
34159
Federal Register / Vol. 88, No. 102 / Friday, May 26, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
TRANSCEND
TRANSCEND
TRANSCEND
TRANSCEND
TRANSCEND
Number of
respondents
Form name
Recipient Data Manager .........
Recipient Data Manager .........
Clients ......................................
Clients ......................................
Recipient Data Manager .........
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–11266 Filed 5–25–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Electronic Health Record Data Form .............
Client Intake Form ..........................................
Client Intake Form ..........................................
Client Satisfaction Survey ..............................
Client Satisfaction Survey ..............................
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2023–11326 Filed 5–25–23; 8:45 am]
World Trade Center Health Program
Scientific/Technical Advisory
Committee; Notice of Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces the renewal
of the charter of the World Trade Center
(WTC) Health Program Scientific/
Technical Advisory Committee (STAC).
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D., M.S.,
Designated Federal Officer, World Trade
Center Health Program Scientific/
Technical Advisory Committee,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop R–12, Atlanta,
Georgia 30329–4027. Telephone: (513)
841–4515; Email: TCarreonValencia@
cdc.gov.
SUMMARY:
CDC is
providing notice under 5 U.S.C. 1001–
1014 of the renewal of the charter of the
WTC Health Program STAC. The STAC
was established by title I of Public Law
111–347 (the James Zadroga 9/11 Health
and Compensation Act of 2010), as
amended by Public Laws 114–113, 116–
59, and 117–328. This charter has been
renewed for a two-year period through
May 12, 2025.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
ddrumheller on DSK120RN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
18:14 May 25, 2023
Jkt 259001
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2023–0040; NIOSH
248–K]
World Trade Center Health Program
Scientific/Technical Advisory
Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP–STAC). This
virtual meeting is open to the public.
Time will be available for public
comment.
SUMMARY:
The meeting will be held on June
21, 2023, from 11 a.m. to 4 p.m., EDT,
and June 22, 2023, from 11 a.m. to 1:30
p.m., EDT.
Written public comments must be
received by June 22, 2023. Members of
the public who wish to address the
WTCHP–STAC during the oral public
comment session must sign up to speak
by June 14, 2023, at the email address
DATES:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
4
4
800
400
4
2
2
1
1
1
Average
burden per
response
(in hours)
8
2
8/60
15/60
2
provided in the Procedure for Oral
Public Comment section below.
ADDRESSES: This is a virtual meeting
conducted via Zoom. The public is
welcome to follow the proceedings via
live webcast at the following link:
https://www.ustream.tv/channel/
QyXBRzYjVCS. No registration is
required. For additional information,
please visit the World Trade Center
Health Program website at https://
www.cdc.gov/wtc/stac_meeting.html.
You may submit comments, identified
by Docket No. CDC–2023–0040; NIOSH
248–K by either of the methods listed
below. CDC does not accept comments
by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Ms. Sherri Diana, NIOSH
Docket Office, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–34,
Cincinnati, Ohio 45226. Attn: Docket
No. CDC–2023–0040; NIOSH 248–K.
Instructions: All submissions received
must include the Agency name and
docket number (CDC–2023–0040;
NIOSH 248–K). The docket will close on
June 22, 2023. All relevant comments,
including any personal information
provided, will be posted without change
to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D., M.S.,
Designated Federal Officer, World Trade
Center Health Program Scientific/
Technical Advisory Committee,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop R–12, Atlanta,
Georgia 30329–4027. Telephone: (513)
841–4515; Email: wtc-stac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The World Trade Center
(WTC) Health Program, including the
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP–STAC), was
established by Title I of the James
Zadroga 9/11 Health and Compensation
Act of 2010, Public Law 111–347, as
E:\FR\FM\26MYN1.SGM
26MYN1
ddrumheller on DSK120RN23PROD with NOTICES1
34160
Federal Register / Vol. 88, No. 102 / Friday, May 26, 2023 / Notices
amended by Public Law 114–113,
Public Law 116–59, and Public Law
117–328 (December 23, 2022), adding
title XXXIII to the Public Health Service
(PHS) Act (codified at 42 U.S.C. 300mm
to 300mm–62). Title XXXIII of the PHS
Act established the WTC Health
Program within the Department of
Health and Human Services. The WTC
Health Program provides medical
monitoring and treatment benefits to
eligible firefighters and related
personnel, law enforcement officers,
and rescue, recovery, and cleanup
workers who responded to the
September 11, 2001, terrorist attacks in
New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders),
and to eligible persons who were
present in the dust or dust cloud on
September 11, 2001, or who worked,
resided, or attended school, childcare,
or adult daycare in the New York City
disaster area (survivors).
All references to the Administrator in
this document mean the Director of the
National Institute for Occupational
Safety and Health (NIOSH), within the
Centers for Disease Control and
Prevention (CDC), or his or her
designee.
Purpose: The purpose of the WTCHP–
STAC is to review scientific and
medical evidence and to make
recommendations to the Administrator
of the WTC Health Program regarding
additional WTC Health Program
eligibility criteria, potential additions to
the List of WTC-Related Health
Conditions (List), and research
regarding certain health conditions
related to the September 11, 2001,
terrorist attacks. In accordance with
section 3312(a)(6)(G)(i)(II), the
Administrator must ask the WTCHP–
STAC to review and evaluate any
substantive amendment to any existing
WTC Health Program policy or
procedure used to determine whether
sufficient evidence exists to support
adding a health condition to the List of
WTC-Related Health Conditions.
The Administrator is responsible for
the administration of the WTCHP–
STAC. CDC and NIOSH provide
funding, staffing, and administrative
support services for the WTCHP–STAC.
The WTCHP–STAC’s charter was
reissued on May 12, 2023, and will
expire on May 12, 2025.
Matters To Be Considered: In
December 2022, the Consolidated
Appropriations Act, 2023 amended
section 3341 of the PHS Act to direct the
Administrator, in consultation with the
Secretary of Education, to establish a
new research cohort to conduct future
research studies on the health and
educational impacts of ‘‘exposure to
VerDate Sep<11>2014
18:14 May 25, 2023
Jkt 259001
airborne toxins, or any other hazard or
adverse condition, resulting from the
September 11, 2001, terrorist attacks,
including on the population of
individuals who were 21 years of age or
younger at the time of exposure,
including such individuals who are
screening-eligible WTC survivors or
certified-eligible WTC survivors.’’ The
main focus of the WTC Health Program
STAC meeting will be a discussion of
the new youth research cohort being
established by the WTC Health Program.
The meeting agenda will include a
presentation on establishing the cohort
and the Program’s perspectives, as well
as an overview of young survivors. In
addition, the WTC Survivors Steering
Committee will lead presentations on
young survivors’ views and communitybased participatory research.
The meeting will also include a
presentation and discussion about
substantive amendments to the existing
Policy and Procedures for Adding NonCancer Health Conditions to the List of
WTC-Related Health Conditions.
Proposed revisions to the Policy and
Procedures were initially presented to
the STAC at its meeting on February 9,
2023; the presentation will detail further
revisions made to the Policy and
Procedures in response to
recommendations of the STAC at its
previous meeting.
Background documents as well as the
agenda for this meeting are available on
the WTC Health Program website at
https://www.cdc.gov/wtc/stac_
meeting.html. Agenda items are subject
to change as priorities dictate.
Public Participation
Interested parties may participate by
submitting written views, opinions,
recommendations, and data. You may
submit comments on any topic related
to the matters to be discussed by the
Committee. Comments received,
including attachments and other
supporting materials, are part of the
public record and subject to public
disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near-duplicate examples of a mass-mail
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
campaign. CDC will carefully consider
all comments submitted into the docket.
Oral Public Comment: The public is
welcome to participate, via Zoom,
during the public comment periods on
June 21, 2023, from 1:20 p.m. to 1:50
p.m., EDT, and on June 22, 2023, from
11:05 a.m. to 11:35 a.m., EDT. Each
commenter will be provided up to five
minutes for comment. A limited number
of time slots are available and will be
assigned on a first-come, first-served
basis.
Procedure for Oral Public Comment:
Members of the public who wish to
address the WTCHP–STAC during the
oral public comment sessions at the
June 21–22, 2023, WTCHP–STAC
meeting must sign up to speak by
providing their name to Ms. Mia
Wallace, Committee Management
Specialist, via email at MWallace@
cdc.gov, by June 14, 2023. Zoom
instructions and participation details
will follow.
Written Public Comment: Written
comments will also be accepted per the
instructions provided in the Addresses
section above. Written public comments
received prior to the meeting will be
part of the official record of the meeting.
The docket will close on June 22, 2023.
Policy on Redaction of Committee
Meeting Transcripts (Public Comment):
Transcripts will be prepared and posted
to https://www.regulations.gov within
60 days after the meeting. If individuals
making a comment give their name, no
attempt will be made to redact the
name. NIOSH will take reasonable steps
to ensure that individuals making
public comments are aware that their
comments (including their names, if
provided) will appear in a transcript of
the meeting posted on a public website.
Such reasonable steps include a
statement read at the start of the meeting
stating that transcripts will be posted,
and names of speakers will not be
redacted. If individuals in making a
statement reveal personal information
(e.g., medical information) about
themselves, that information will not
usually be redacted. The CDC Freedom
of Information Act coordinator will,
however, review such revelations in
accordance with the Freedom of
Information Act and, if deemed
appropriate, will redact such
information. Disclosures of information
concerning third-party medical
information will be redacted.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
E:\FR\FM\26MYN1.SGM
26MYN1
34161
Federal Register / Vol. 88, No. 102 / Friday, May 26, 2023 / Notices
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–11327 Filed 5–25–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing infocollection@
acf.hhs.gov. Identify all emailed
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: State and Tribal title IV–
E agencies are required to report
AFCARS case-level information on all
children in foster care and children who
have been adopted or placed in a
ADDRESSES:
Submission for OMB Review: Adoption
and Foster Care Analysis and
Reporting System (AFCARS) (OMB
#0970–0422)
Children’s Bureau,
Administration for Children and
Families, Department of Health and
Human Services (HHS).
ACTION: Request for public comments.
AGENCY:
The Children’s Bureau (CB),
the Administration for Children and
Families (ACF) is requesting a threeyear extension of the data information
collection for the Adoption and Foster
Care Analysis and Reporting System
(AFCARS) that was implemented as part
of the AFCARS final rule published in
May 2020 (85 FR 28410). There are no
proposed changes to the data
SUMMARY:
information collection published as the
regulation in May 2020. The estimated
time per response related to record
keeping has been revised since the
previous published notice (88 FR 16449)
due to feedback from the State and
Tribal reporting agencies.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
Total
number of
respondents
Instrument
AFCARS—Recordkeeping ...................................................
AFCARS—Reporting ...........................................................
Estimated Total Annual Burden
Hours: 1,180,590.
Authority: Section 479 of the Social
Security Act and 45 CFR 1355.44–45.
69
69
3
6
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2022–D–0737]
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2023–11291 Filed 5–25–23; 8:45 am]
BILLING CODE 4184–25–P
ddrumheller on DSK120RN23PROD with NOTICES1
Total
number of
responses per
respondent
Non-Clinical Performance Assessment
of Tissue Containment Systems Used
During Power Morcellation
Procedures; Guidance for Industry and
Food and Drug Administration Staff;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance entitled ‘‘Non-Clinical
SUMMARY:
VerDate Sep<11>2014
18:14 May 25, 2023
Jkt 259001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
guardianship with title IV–E agency
involvement. The data collected will
inform policy decisions, program
management, and responses to
Congressional and Departmental
inquiries. Specifically, the data are used
for short/long-term budget projections,
trend analysis, child and family service
reviews, and to target areas for
improved technical assistance. The data
will provide information on the number
of children in foster care, the reasons
they enter and exit care, and how to
prevent their unnecessary placement in
foster care. Specifically, the data
include information about children who
enter foster care, their entries and exits,
placement details, and foster/adoptive
parent information. This extension
request is unrelated to any potential
new regulatory activity that may occur
subsequently. This request is for public
comment on the burden calculations. It
does not seek comment on the data
elements that have been through the
rulemaking process.
Respondents: Title IV–E State and
Tribal Child Welfare Agencies.
Annual Burden Estimates
The following annual burden
estimates have been updated to reflect
feedback received from the States and
Tribes after the first notice published on
May 15, 2023 (88 FR 16449). This
feedback encouraged ACF to increase
the estimated hours per response for
recordkeeping.
Average
burden hours
per response
17,076
17
Total
burden hours
3,534,732
7,038
Annual
burden hours
1,178,244
2,346
Performance Assessment of Tissue
Containment Systems Used During
Power Morcellation Procedures.’’ This
guidance document provides
recommendations that may help
manufacturers comply with the special
controls related to non-clinical
performance data for gynecologic and
general laparoscopic power
morcellation containment systems
(‘‘tissue containment systems’’). Tissue
containment systems are used to enable
isolation and containment of tissue
during a power morcellation procedure
performed following a laparoscopic
procedure for the excision of benign
tissue that is not suspected to contain
malignancy.
E:\FR\FM\26MYN1.SGM
26MYN1
]]>Agencies
[Federal Register Volume 88, Number 102 (Friday, May 26, 2023)]
[Notices]
[Pages 34159-34161]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11327]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0040; NIOSH 248-K]
World Trade Center Health Program Scientific/Technical Advisory
Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP-STAC). This virtual meeting is open to the public.
Time will be available for public comment.
DATES: The meeting will be held on June 21, 2023, from 11 a.m. to 4
p.m., EDT, and June 22, 2023, from 11 a.m. to 1:30 p.m., EDT.
Written public comments must be received by June 22, 2023. Members
of the public who wish to address the WTCHP-STAC during the oral public
comment session must sign up to speak by June 14, 2023, at the email
address provided in the Procedure for Oral Public Comment section
below.
ADDRESSES: This is a virtual meeting conducted via Zoom. The public is
welcome to follow the proceedings via live webcast at the following
link: https://www.ustream.tv/channel/QyXBRzYjVCS. No registration is
required. For additional information, please visit the World Trade
Center Health Program website at https://www.cdc.gov/wtc/stac_meeting.html.
You may submit comments, identified by Docket No. CDC-2023-0040;
NIOSH 248-K by either of the methods listed below. CDC does not accept
comments by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Ms. Sherri Diana, NIOSH Docket Office, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, 1090 Tusculum Avenue, Mailstop C-34,
Cincinnati, Ohio 45226. Attn: Docket No. CDC-2023-0040; NIOSH 248-K.
Instructions: All submissions received must include the Agency name
and docket number (CDC-2023-0040; NIOSH 248-K). The docket will close
on June 22, 2023. All relevant comments, including any personal
information provided, will be posted without change to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
M.S., Designated Federal Officer, World Trade Center Health Program
Scientific/Technical Advisory Committee, National Institute for
Occupational Safety and Health, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop R-12, Atlanta, Georgia
30329-4027. Telephone: (513) 841-4515; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The World Trade Center (WTC) Health Program, including
the World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP-STAC), was established by Title I of the James Zadroga
9/11 Health and Compensation Act of 2010, Public Law 111-347, as
[[Page 34160]]
amended by Public Law 114-113, Public Law 116-59, and Public Law 117-
328 (December 23, 2022), adding title XXXIII to the Public Health
Service (PHS) Act (codified at 42 U.S.C. 300mm to 300mm-62). Title
XXXIII of the PHS Act established the WTC Health Program within the
Department of Health and Human Services. The WTC Health Program
provides medical monitoring and treatment benefits to eligible
firefighters and related personnel, law enforcement officers, and
rescue, recovery, and cleanup workers who responded to the September
11, 2001, terrorist attacks in New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders), and to eligible persons who
were present in the dust or dust cloud on September 11, 2001, or who
worked, resided, or attended school, childcare, or adult daycare in the
New York City disaster area (survivors).
All references to the Administrator in this document mean the
Director of the National Institute for Occupational Safety and Health
(NIOSH), within the Centers for Disease Control and Prevention (CDC),
or his or her designee.
Purpose: The purpose of the WTCHP-STAC is to review scientific and
medical evidence and to make recommendations to the Administrator of
the WTC Health Program regarding additional WTC Health Program
eligibility criteria, potential additions to the List of WTC-Related
Health Conditions (List), and research regarding certain health
conditions related to the September 11, 2001, terrorist attacks. In
accordance with section 3312(a)(6)(G)(i)(II), the Administrator must
ask the WTCHP-STAC to review and evaluate any substantive amendment to
any existing WTC Health Program policy or procedure used to determine
whether sufficient evidence exists to support adding a health condition
to the List of WTC-Related Health Conditions.
The Administrator is responsible for the administration of the
WTCHP-STAC. CDC and NIOSH provide funding, staffing, and administrative
support services for the WTCHP-STAC. The WTCHP-STAC's charter was
reissued on May 12, 2023, and will expire on May 12, 2025.
Matters To Be Considered: In December 2022, the Consolidated
Appropriations Act, 2023 amended section 3341 of the PHS Act to direct
the Administrator, in consultation with the Secretary of Education, to
establish a new research cohort to conduct future research studies on
the health and educational impacts of ``exposure to airborne toxins, or
any other hazard or adverse condition, resulting from the September 11,
2001, terrorist attacks, including on the population of individuals who
were 21 years of age or younger at the time of exposure, including such
individuals who are screening-eligible WTC survivors or certified-
eligible WTC survivors.'' The main focus of the WTC Health Program STAC
meeting will be a discussion of the new youth research cohort being
established by the WTC Health Program. The meeting agenda will include
a presentation on establishing the cohort and the Program's
perspectives, as well as an overview of young survivors. In addition,
the WTC Survivors Steering Committee will lead presentations on young
survivors' views and community-based participatory research.
The meeting will also include a presentation and discussion about
substantive amendments to the existing Policy and Procedures for Adding
Non-Cancer Health Conditions to the List of WTC-Related Health
Conditions. Proposed revisions to the Policy and Procedures were
initially presented to the STAC at its meeting on February 9, 2023; the
presentation will detail further revisions made to the Policy and
Procedures in response to recommendations of the STAC at its previous
meeting.
Background documents as well as the agenda for this meeting are
available on the WTC Health Program website at https://www.cdc.gov/wtc/stac_meeting.html. Agenda items are subject to change as priorities
dictate.
Public Participation
Interested parties may participate by submitting written views,
opinions, recommendations, and data. You may submit comments on any
topic related to the matters to be discussed by the Committee. Comments
received, including attachments and other supporting materials, are
part of the public record and subject to public disclosure. Do not
include any information in your comment or supporting materials that
you consider confidential or inappropriate for public disclosure. If
you include your name, contact information, or other information that
identifies you in the body of your comments, that information will be
on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near-duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into
the docket.
Oral Public Comment: The public is welcome to participate, via
Zoom, during the public comment periods on June 21, 2023, from 1:20
p.m. to 1:50 p.m., EDT, and on June 22, 2023, from 11:05 a.m. to 11:35
a.m., EDT. Each commenter will be provided up to five minutes for
comment. A limited number of time slots are available and will be
assigned on a first-come, first-served basis.
Procedure for Oral Public Comment: Members of the public who wish
to address the WTCHP-STAC during the oral public comment sessions at
the June 21-22, 2023, WTCHP-STAC meeting must sign up to speak by
providing their name to Ms. Mia Wallace, Committee Management
Specialist, via email at [email protected], by June 14, 2023. Zoom
instructions and participation details will follow.
Written Public Comment: Written comments will also be accepted per
the instructions provided in the Addresses section above. Written
public comments received prior to the meeting will be part of the
official record of the meeting. The docket will close on June 22, 2023.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If individuals
making a comment give their name, no attempt will be made to redact the
name. NIOSH will take reasonable steps to ensure that individuals
making public comments are aware that their comments (including their
names, if provided) will appear in a transcript of the meeting posted
on a public website. Such reasonable steps include a statement read at
the start of the meeting stating that transcripts will be posted, and
names of speakers will not be redacted. If individuals in making a
statement reveal personal information (e.g., medical information) about
themselves, that information will not usually be redacted. The CDC
Freedom of Information Act coordinator will, however, review such
revelations in accordance with the Freedom of Information Act and, if
deemed appropriate, will redact such information. Disclosures of
information concerning third-party medical information will be
redacted.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other
[[Page 34161]]
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and Disease
Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-11327 Filed 5-25-23; 8:45 am]
BILLING CODE 4163-18-P
